Financhill
Back

Bristol-Myers Squibb Vs. Collegium Pharmaceutical Industry Stock Comparison

Sell
43

BMY
Bristol-Myers Squibb

Last Price:
$56.86
Seasonality Move:
0.2%
Sell
45

COLL
Collegium Pharmaceutical

Last Price:
$33.33
Seasonality Move:
-1.63%
Sell
43
Bristol-Myers Squibb (BMY) is a Sell

Is Bristol-Myers Squibb a Buy, Sell or Hold?

  • The current Bristol-Myers Squibb [BMY] share price is $56.81. The Score for BMY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • BMY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Collegium Pharmaceutical (COLL) is a Sell

Is Collegium Pharmaceutical a Buy, Sell or Hold?

  • The current Collegium Pharmaceutical [COLL] share price is $33.34. The Score for COLL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • COLL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BMY Stock Price Chart

What is Bristol-Myers Squibb's stock price today?

  • The Bristol-Myers Squibb share price today is $56.81
    The current trend is relatively stagnant and BMY is experiencing buying pressure, which is a positive indicator for future bullish movement.

COLL Stock Price Chart

What is Collegium Pharmaceutical's stock price today?

  • The Collegium Pharmaceutical share price today is $33.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COLL is experiencing buying pressure, which is a positive indicator for future bullish movement.

BMY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 48.35 Sell
Chaikin Money Flow: 5741363 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (56.32 - 58.28) Sell
Bollinger Bands (100): (50.17 - 57.57) Buy

COLL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 66.05 Buy
Chaikin Money Flow: 1007158 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.9 - 30.94) Buy
Bollinger Bands (100): (30.52 - 37.92) Sell

BMY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.79 Buy
20-day SMA: 56.92 Sell
50-day SMA: 57.08 Sell
200-day SMA: 49.46 Buy
8-day EMA: 56.89 Sell
20-day EMA: 57.07 Sell
50-day EMA: 56.34 Buy
200-day EMA: 52.55 Buy

COLL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.45 Buy
20-day SMA: 29.79 Buy
50-day SMA: 30.91 Buy
200-day SMA: 34.47 Sell
8-day EMA: 30.02 Buy
20-day EMA: 29.94 Buy
50-day EMA: 31.21 Buy
200-day EMA: 32.94 Buy

Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.14 per share, and a decrease next year of $0.73 per share.

Collegium Pharmaceutical Earnings Growth & COLL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $0.51 per share.

Bristol-Myers Squibb Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Collegium Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):